Literature DB >> 23190005

Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.

I Straub1, F Mohr, J Stab, M Konrad, S E Philipp, J Oberwinkler, M Schaefer.   

Abstract

BACKGROUND AND
PURPOSE: The melastatin-related transient receptor potential TRPM3 is a calcium-permeable nonselective cation channel that can be activated by the neurosteroid pregnenolone sulphate (PregS) and heat. TRPM3-deficient mice show an impaired perception of noxious heat. Hence, drugs inhibiting TRPM3 possibly get in focus of analgesic therapy. EXPERIMENTAL APPROACH: Fluorometric methods were used to identify novel TRPM3-blocking compounds and to characterize their potency and selectivity to block TRPM3 but not other sensory TRP channels. Biophysical properties of the block were assessed using electrophysiological methods. Single cell calcium measurements confirmed the block of endogenously expressed TRPM3 channels in rat and mouse dorsal root ganglion (DRG) neurones. KEY
RESULTS: By screening a compound library, we identified three natural compounds as potent blockers of TRPM3. Naringenin and hesperetin belong to the citrus fruit flavanones, and ononetin is a deoxybenzoin. Eriodictyol, a metabolite of naringenin and hesperetin, was still biologically active as a TRPM3 blocker. The compounds exhibited a marked specificity for recombinant TRPM3 and blocked PregS-induced [Ca(2+)]i signals in freshly isolated DRG neurones. CONCLUSION AND IMPLICATIONS: The data indicate that citrus fruit flavonoids are potent and selective blockers of TRPM3. Their potencies ranged from upper nanomolar to lower micromolar concentrations. Since physiological functions of TRPM3 channels are still poorly defined, the development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo. Considering the involvement of TRPM3 in nociception, TRPM3 blockers may represent a novel concept for analgesic treatment.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23190005      PMCID: PMC3623054          DOI: 10.1111/bph.12076

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  TRPV1 acts as proton channel to induce acidification in nociceptive neurons.

Authors:  Nicole Hellwig; Tim D Plant; Wiebke Janson; Michael Schäfer; Günter Schultz; Michael Schaefer
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

2.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.

Authors:  Paula A Zamudio-Bulcock; Julie Everett; Christian Harteneck; C Fernando Valenzuela
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

4.  Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect.

Authors:  Shang-Zhong Xu; Fanning Zeng; Guylain Boulay; Christian Grimm; Christian Harteneck; David J Beech
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  TRPM3 is a nociceptor channel involved in the detection of noxious heat.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Hofmann; Stephan E Philipp; Julia Stab; Xiaodi Chen; Melissa Benoit; Fenqin Xue; Annelies Janssens; Sara Kerselaers; Johannes Oberwinkler; Rudi Vennekens; Thomas Gudermann; Bernd Nilius; Thomas Voets
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

6.  Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels.

Authors:  Yasser Majeed; Yahya Bahnasi; Victoria A L Seymour; Lesley A Wilson; Carol J Milligan; Anil K Agarwal; Piruthivi Sukumar; Jacqueline Naylor; David J Beech
Journal:  Mol Pharmacol       Date:  2011-03-15       Impact factor: 4.436

7.  LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability.

Authors:  M J Nadler; M C Hermosura; K Inabe; A L Perraud; Q Zhu; A J Stokes; T Kurosaki; J P Kinet; R Penner; A M Scharenberg; A Fleig
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

Review 8.  Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.

Authors:  O Benavente-García; J Castillo
Journal:  J Agric Food Chem       Date:  2008-07-02       Impact factor: 5.279

9.  The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Authors:  U Fuhr; A L Kummert
Journal:  Clin Pharmacol Ther       Date:  1995-10       Impact factor: 6.875

10.  Herbal compounds and toxins modulating TRP channels.

Authors:  Joris Vriens; Bernd Nilius; Rudi Vennekens
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more
  31 in total

Review 1.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

3.  The pharmacology of TRP channels.

Authors:  Peter Holzer; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

4.  Tart cherry (Prunus cerasus L.) dietary supplement modulates visceral adipose tissue CB1 mRNA levels along with other adipogenesis-related genes in rat models of diet-induced obesity.

Authors:  Paolo Cocci; Michele Moruzzi; Ilenia Martinelli; Federica Maggi; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Gilberto Mosconi; Seyed Khosrow Tayebati; Silvia Damiano; Giulio Lupidi; Consuelo Amantini; Daniele Tomassoni; Francesco Alessandro Palermo
Journal:  Eur J Nutr       Date:  2021-01-02       Impact factor: 5.614

5.  The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Loipa Galán; Ariel Talavera; Julio L Alvarez; Karel Talavera
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

6.  Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits.

Authors:  Omar Alkhatib; Robson da Costa; Clive Gentry; Talisia Quallo; Stuart Bevan; David A Andersson
Journal:  J Neurosci       Date:  2019-08-26       Impact factor: 6.167

7.  Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells.

Authors:  G Y Son; Y M Yang; W S Park; I Chang; D M Shin
Journal:  J Dent Res       Date:  2015-01-16       Impact factor: 6.116

8.  Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.

Authors:  Andrea Lesch; Sandra Rubil; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  Naringenin mitigates titanium dioxide (TiO2)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB.

Authors:  Marília F Manchope; Nayara A Artero; Victor Fattori; Sandra S Mizokami; Dimitrius L Pitol; João P M Issa; Sandra Y Fukada; Thiago M Cunha; José C Alves-Filho; Fernando Q Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2018-10-28       Impact factor: 4.575

10.  Rational Design of Novel Allosteric Dihydrofolate Reductase Inhibitors Showing Antibacterial Effects on Drug-Resistant Escherichia coli Escape Variants.

Authors:  Bharath Srinivasan; João V Rodrigues; Sam Tonddast-Navaei; Eugene Shakhnovich; Jeffrey Skolnick
Journal:  ACS Chem Biol       Date:  2017-05-31       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.